Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)
Article content VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by $400,000 to support the launch…